Nov 08, 2023 / 08:20PM GMT
Robyn Kay Shelton Karnauskas - Truist Securities, Inc., Research Division - Research Analyst
Good morning, everyone. What a delight to have Dr. Len Schleifer here today. I think I've known Len since I was a baby analyst. A really bad one, but much better now. And with them, we also have Ryan Crowe from Investor Relations as well. So thank you so much. Before we begin, both of us have to disclosures. So here are mine, because this is being webcast. So don't scream anything out, it's going to be transcribed and live. This call is arranged by Truist Securities Research for institutional investors and issuer clients only as defined by FINRA. If you're not an individual investor or issuer, please disconnect this time. For required disclosures, please see our website at truistsecurities.com or equity research library. So with that, I'll turn it over to you.
Ryan Crowe - Regeneron Pharmaceuticals, Inc. - VP of IR
Now it's my turn. Thank you, Robyn, for hosting us here at Truist. Great to be here. I'd like to remind you that our remarks made today may include forward
Regeneron Pharmaceuticals Inc at Truist BioPharma Symposium Transcript
Nov 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers